Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KP.1.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KP.1.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KP.1.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KP.1.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KP.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LB.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LB.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LB.1.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LB.1.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
LB.1.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
LB.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LB.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.3.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KP.3.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.3.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KP.3.3.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KP.3.3.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KP.3.3.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KP.3.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.3.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDYEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XDYEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDYECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
XDYECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XDYEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XDYEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XDYENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDYENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.18.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.18.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.18.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.18.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.18.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.18.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.18.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.18.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.9EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.9ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.9ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.9EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.9EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.44EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.44EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.44ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.44ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used